Slate Path Capital LP - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 86 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Slate Path Capital LP ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2020$6,119,000
+71.2%
420,0000.0%0.36%
+31.8%
Q1 2020$3,574,000
-47.0%
420,000
-11.6%
0.27%
+33.7%
Q4 2016$6,745,000
-33.6%
475,0000.0%0.20%
+21.3%
Q3 2016$10,160,000
+7.5%
475,000
+13.1%
0.17%
-77.1%
Q2 2016$9,454,000420,0000.74%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$1,610,00011.42%
Redmile Group, LLC 6,048,123$9,737,4780.37%
Baupost Group 9,773,616$15,7360.28%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 170,000$273,7000.27%
MAVERICK CAPITAL LTD 6,290,713$10,128,0480.22%
683 Capital Management, LLC 1,000,000$1,610,0000.12%
WASATCH ADVISORS LP 8,283,981$13,337,2090.08%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$845,2500.08%
STALEY CAPITAL ADVISERS INC 750,000$1,207,5000.06%
XTX Topco Ltd 136,841$220,3140.04%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders